Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 20, 2019 at 03:36 pm IST
Share
HST Global, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 34,758 compared to USD 35,456 a year ago. Net loss was USD 43,695 compared to USD 44,393 a year ago. For the half year, operating loss was USD 71,066 compared to USD 73,332 a year ago. Net loss was USD 88,940 compared to USD 91,206 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.